TODAY'S HEADLINES

First olmesartan generics approved for hypertension

In a big move for patients who take blood pressure medication on a regular basis, FDA approved the generic versions of 4 drugs that contain the blood pressure-lowering medication olmesartan medoxomil (Benicar). Read more

Insurer diabetes program engages consumers, lowers costs

Anthem Blue Cross recently launched a year-long diabetes prevention program to educate, treat and support its qualified California members who are at risk of developing type 2 diabetes. Find out the results

CONTINUING PHARMACY EDUCATION

Rheumatoid arthritis: partnering for optimal care

This month's CE activity, "Rheumatoid arthritis: partnering for optimal care," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians in how to best assist patients in the use of medications to treat rheumatoid arthritis.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

First "artificial pancreas" for diabetes approved, plus 2 more FDA actions

FDA recently approved the first device to automatically monitor blood sugar and provide appropriate basal insulin doses for patients with type 1 diabetes, plus two new medicines. Read more

November 02, 2016

Related Articles

Health costs rise for diabetes patients

Statin prescribing varies in patients with diabetes